GALLENGA, Carla Enrica
GALLENGA, Carla Enrica
Dipartimento di Morfologia, chirurgia e medicina sperimentale (attivo dal 01/10/2012 al 31/12/2022)
A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: A better understanding of the pathophysiology using the newest genetic strategies
2016 Sorrentino, F. S; Gallenga, Carla Enrica; Bonifazzi, Claudio; Perri, P.
A New Pharmacological Approach Based on Remdesivir Aerosolized Administration on SARS-CoV-2 Pulmonary Inflammation: A Possible and Rational Therapeutic Application
2020 Contini, C.; Gallenga, Ce.; Neri, Gp.; Maritati, M.; Conti, P
About Chlamydia trachomatis. Reply to Garcia-Teillard et al. Trachoma and the Importance of Sexual Infective Route in Developed Countries. Comment on “Gallenga et al. Why the SAFE—S Strategy for Trachoma? Are Musca sorbens or Scatophaga stercoraria Really the Culprit?—A Brief Historical Review from an Italian Point of View. Pathogens 2023, 12, 1419”
file con accesso da definire2024 Maritati, Martina; Contini, Carlo; Del Boccio, Marco; D’Aloisio, Rossella; Conti, Pio; Mura, Marco; Enrico Gallenga, Pier; Gallenga, Carla Enrica
Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines
file con accesso da definire2023 Lauritano, Dorina; Mastrangelo, Filiberto; D'Ovidio, Cristian; Ronconi, Gianpaolo; Caraffa, Alessandro; Gallenga, Carla E; Frydas, Ilias; Kritas, Spyros K; Trimarchi, Matteo; Carinci, Francesco; Conti, Pio
Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection
2022 Rotondo, J. C.; Martini, F.; Maritati, M.; Caselli, E.; Gallenga, C. E.; Guarino, M.; De Giorgio, R.; Mazziotta, C.; Tramarin, M. L.; Badiale, G.; Tognon, M.; Contini, C.
Determination of the soluble form of the P2X7 receptor in aqueous humour, vitreous humour and serum under normal and pathological conditions: sP2X7R as an indicator of ocular inflammatory status.
2023 Gallenga, Carla Enrica
Diagnosis of a Neonatal Ophthalmic Discharge, Ophthalmia Neonatorum, in the “Molecular Age”: Investigation for a Correct Therapy
2018 Gallenga, Pe.; Del Boccio, M.; Gallenga, C. E.; Neri, G.; Pennelli, A.; Toniato, E.; Lobefalo, L.; Maritati, M.; Perri, P.; Contini, C.; Del Boccio, G.
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration
2015 Parmeggiani, Francesco; Costagliola, Ciro; Semeraro, Francesco; Romano, Mario R; Rinaldi, Michele; Gallenga, Carla Enrica; Serino, Maria Luisa; Incorvaia, Carlo; D'Angelo, Sergio; DE NADAI, Katia; Dell’Omo, Roberto; Russo, Andrea; Gemmati, Donato; Perri, Paolo
Evaluation of Anti-SARS-CoV-2 IgA Response in Tears of Vaccinated COVID-19 Subjects
2023 Soffritti, Irene; D'Accolti, Maria; Gallenga, Carla; De Giorgio, Roberto; Guarino, Matteo; Maritati, Martina; Bini, Francesca; Mazziga, Eleonora; Contini, Carlo; Caselli, Elisabetta
How to classify the covid-19 phenotype: a response from "the first soldier in the first trench" in Lombardy, north-western Italy
2021 Gallenga, C. E.; Contini, C.; Tana, M.; D'Eliseo, D.; Giuliani, A. L.; Di Virgilio, F.; Paglia, S.
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration
2019 Parmeggiani, F; Gallenga, Ce; Costagliola, C; Semeraro, F; Romano, Mr; Dell'Omo, R; Russo, A; De Nadai, K; Gemmati, D; D'Angelo, S; Bolletta, E; Sorrentino, Fs
Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation
file con accesso da definire2024 Conti, Pio; Ronconi, Gianpaolo; Lauritano, Dorina; Mastrangelo, Filiberto; Caraffa, Alessandro; Gallenga, Carla E; Frydas, Ilias; Kritas, Spyridon K; Carinci, Francesco; Gaudelli, Federico; Annicchiarico, Ciro; D'Ovidio, Cristian
Improving visual activity using Gabor patch technology in Stargardt disease: a retrospective study
2018 Mincarelli, C; Gallenga, Ce; Colangelo, L; Lobefalo, L; Di Carlo, Pg; Nuri, M; Parmeggiani, F; Perri, P.
Inflammaging: should this term be suitable for age related macular degeneration too?
file con accesso da definire2014 Gallenga, Carla Enrica; Parmeggiani, Francesco; Ciro, Costagliola; Sebastiani, Adolfo; Pier Enrico Gallenga,
Macrophage Activation in Follicular Conjunctivitis during the COVID-19 Pandemic
2023 Gallenga, C. E.; Maritati, M.; Mura, M.; Di Virgilio, F.; Conti, P.; Contini, C
Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37
2022 Trimarchi, Matteo; Lauritano, Dorina; Ronconi, Gianpaolo; Caraffa, Alessandro; Gallenga, Carla E; Frydas, Ilias; Kritas, Spyros K; Calvisi, Ernesto; Conti, Pio
Mast cells mediate rheumatoid arthritis—inhibitory role of IL-37
file con accesso da definire2019 Conti, P.; Lauritano, D.; Caraffa, A.; Gallenga, C. E.; Carinci, F.; Ronconi, G.; Kritas, S. K.; Di Emidio, P.; Martinotti, S.; Pandolfi, F.
Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37
2020 Conti, P.; Lauritano, D.; Caraffa, A.; Gallenga, C. E.; Kritas, S. K.; Ronconi, G.; Martinotti, S.
New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma
2019 Violanti, S. S.; Bononi, I.; Gallenga, C. E.; Martini, F.; Tognon, M.; Perri, P.
Psoriatic uveitis is not an exploded myth
2017 Gallenga, Ce; Parmeggiani, F; Monari, P; Perri, P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: A better understanding of the pathophysiology using the newest genetic strategies | 2016 | Sorrentino, F. S; Gallenga, Carla Enrica; Bonifazzi, Claudio; Perri, P. | |
| A New Pharmacological Approach Based on Remdesivir Aerosolized Administration on SARS-CoV-2 Pulmonary Inflammation: A Possible and Rational Therapeutic Application | 2020 | Contini, C.; Gallenga, Ce.; Neri, Gp.; Maritati, M.; Conti, P | |
| About Chlamydia trachomatis. Reply to Garcia-Teillard et al. Trachoma and the Importance of Sexual Infective Route in Developed Countries. Comment on “Gallenga et al. Why the SAFE—S Strategy for Trachoma? Are Musca sorbens or Scatophaga stercoraria Really the Culprit?—A Brief Historical Review from an Italian Point of View. Pathogens 2023, 12, 1419” | 2024 | Maritati, Martina; Contini, Carlo; Del Boccio, Marco; D’Aloisio, Rossella; Conti, Pio; Mura, Marc...o; Enrico Gallenga, Pier; Gallenga, Carla Enrica | file con accesso da definire |
| Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines | 2023 | Lauritano, Dorina; Mastrangelo, Filiberto; D'Ovidio, Cristian; Ronconi, Gianpaolo; Caraffa, Aless...andro; Gallenga, Carla E; Frydas, Ilias; Kritas, Spyros K; Trimarchi, Matteo; Carinci, Francesco; Conti, Pio | file con accesso da definire |
| Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection | 2022 | Rotondo, J. C.; Martini, F.; Maritati, M.; Caselli, E.; Gallenga, C. E.; Guarino, M.; De Giorgio,... R.; Mazziotta, C.; Tramarin, M. L.; Badiale, G.; Tognon, M.; Contini, C. | |
| Determination of the soluble form of the P2X7 receptor in aqueous humour, vitreous humour and serum under normal and pathological conditions: sP2X7R as an indicator of ocular inflammatory status. | 2023 | Gallenga, Carla Enrica | |
| Diagnosis of a Neonatal Ophthalmic Discharge, Ophthalmia Neonatorum, in the “Molecular Age”: Investigation for a Correct Therapy | 2018 | Gallenga, Pe.; Del Boccio, M.; Gallenga, C. E.; Neri, G.; Pennelli, A.; Toniato, E.; Lobefalo, L....; Maritati, M.; Perri, P.; Contini, C.; Del Boccio, G. | |
| Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration | 2015 | Parmeggiani, Francesco; Costagliola, Ciro; Semeraro, Francesco; Romano, Mario R; Rinaldi, Michele...; Gallenga, Carla Enrica; Serino, Maria Luisa; Incorvaia, Carlo; D'Angelo, Sergio; DE NADAI, Katia; Dell’Omo, Roberto; Russo, Andrea; Gemmati, Donato; Perri, Paolo | |
| Evaluation of Anti-SARS-CoV-2 IgA Response in Tears of Vaccinated COVID-19 Subjects | 2023 | Soffritti, Irene; D'Accolti, Maria; Gallenga, Carla; De Giorgio, Roberto; Guarino, Matteo; Marita...ti, Martina; Bini, Francesca; Mazziga, Eleonora; Contini, Carlo; Caselli, Elisabetta | |
| How to classify the covid-19 phenotype: a response from "the first soldier in the first trench" in Lombardy, north-western Italy | 2021 | Gallenga, C. E.; Contini, C.; Tana, M.; D'Eliseo, D.; Giuliani, A. L.; Di Virgilio, F.; Paglia, S. | |
| Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration | 2019 | Parmeggiani, F; Gallenga, Ce; Costagliola, C; Semeraro, F; Romano, Mr; Dell'Omo, R; Russo, A; De ...Nadai, K; Gemmati, D; D'Angelo, S; Bolletta, E; Sorrentino, Fs | |
| Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation | 2024 | Conti, Pio; Ronconi, Gianpaolo; Lauritano, Dorina; Mastrangelo, Filiberto; Caraffa, Alessandro; G...allenga, Carla E; Frydas, Ilias; Kritas, Spyridon K; Carinci, Francesco; Gaudelli, Federico; Annicchiarico, Ciro; D'Ovidio, Cristian | file con accesso da definire |
| Improving visual activity using Gabor patch technology in Stargardt disease: a retrospective study | 2018 | Mincarelli, C; Gallenga, Ce; Colangelo, L; Lobefalo, L; Di Carlo, Pg; Nuri, M; Parmeggiani, F; Pe...rri, P. | |
| Inflammaging: should this term be suitable for age related macular degeneration too? | 2014 | Gallenga, Carla Enrica; Parmeggiani, Francesco; Ciro, Costagliola; Sebastiani, Adolfo; Pier Enric...o Gallenga, | file con accesso da definire |
| Macrophage Activation in Follicular Conjunctivitis during the COVID-19 Pandemic | 2023 | Gallenga, C. E.; Maritati, M.; Mura, M.; Di Virgilio, F.; Conti, P.; Contini, C | |
| Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37 | 2022 | Trimarchi, Matteo; Lauritano, Dorina; Ronconi, Gianpaolo; Caraffa, Alessandro; Gallenga, Carla E;... Frydas, Ilias; Kritas, Spyros K; Calvisi, Ernesto; Conti, Pio | |
| Mast cells mediate rheumatoid arthritis—inhibitory role of IL-37 | 2019 | Conti, P.; Lauritano, D.; Caraffa, A.; Gallenga, C. E.; Carinci, F.; Ronconi, G.; Kritas, S. K.; ...Di Emidio, P.; Martinotti, S.; Pandolfi, F. | file con accesso da definire |
| Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37 | 2020 | Conti, P.; Lauritano, D.; Caraffa, A.; Gallenga, C. E.; Kritas, S. K.; Ronconi, G.; Martinotti, S. | |
| New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma | 2019 | Violanti, S. S.; Bononi, I.; Gallenga, C. E.; Martini, F.; Tognon, M.; Perri, P. | |
| Psoriatic uveitis is not an exploded myth | 2017 | Gallenga, Ce; Parmeggiani, F; Monari, P; Perri, P |